Abstract: In the present disclosure, a piece is disposed on a glove core of a glove structure, and an edge of the piece is to injected and filled with molding material to have an injection molding assembly thereon. The injection molding assembly at least fills a section gap between the glove core and the edge of the piece. By using the injection molding assembly, the section gap between the glove core and the edge of the piece is masked, and an adhesive effect for bonding the piece is also obtained. Thus, the present disclosure provides positive and reliable means for preventing the edge of the piece from being separated from the glove core, making the glove structure maintain its required function in long term, increasing the quality and the lifetime of the glove structure, and making the glove structure have a curved surface shape to present its three-dimensional shape.

Abstract: A mask, a mask assembly, an exposure machine, a method for testing shadowing effect on a window, and a photolithography method are provided. The mask includes a light transmission area; a functional window provided at a side of the light transmission area; and at least one of a first detection mark and a second detection mark; wherein the first detection mark is flushed with a border of the functional window adjacent to an interior of the mask; and the second detection mark is disposed between the profile of the light transmission area and the functional window.

Abstract: Provided is a quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity, specifically, provided is a compound of general Formula (I) or pharmaceutically acceptable salt thereof, its pharmaceutical composition, preparation method and use in the manufacture of a medicament for immunomodulating and preventing and/or treating of a disease associated with IDO expression abnormality and/or tryptophan metabolism abnormality. Also provided is use of a combination medication of the quinoline derivative and HDAC inhibitor and its use in the manufacture of an anti-tumor drug.

Abstract: A mask, a mask assembly, an exposure machine, a method for testing shadowing effect on a window, and a photolithography method are provided. The mask includes a light transmission area; a functional window provided at a side of the light transmission area; and at least one of a first detection mark and a second detection mark; wherein the first detection mark is flushed with a border of the functional window adjacent to an interior of the mask; and the second detection mark is disposed between the profile of the light transmission area and the functional window.

Abstract: A glove has a glove core and a glove component. The glove core has a palm portion, a dorsum portion, a side portion of hand and a finger portion; the palm portion and the finger portion are connected to each other via a connection point, the finger piece portion has a first and second bonding portions with a distance therebetween, the finger piece portion is bound to the finger portion via the first bonding portion, and the finger piece portion is bound to the palm portion via the second bonding portion. The connection point, the first bonding portion and the second bonding portion are formed to have a virtual triangle, thus the finger portion and the palm portion have an angle being less than 180 degrees, and that is, the finger portion bends forward the palm portion to make the glove comply with the ergonomic principle.

Abstract: The present invention relates to a formamide compound, a preparation method therefor and an application thereof. The structure of the compound is shown in formula (I), and the definition of each variable in the formula is as provided in the description. The compound is capable of inhibiting the activity of ASK1 kinase. The compound of the present invention may be used in the treatment/prevention of diseases associated with ASK1 kinase, such as inflammatory diseases, metabolic diseases, autoimmune diseases, cardiovascular diseases, neurodegenerative diseases, cancers and other diseases.

Abstract: A glove structure of the present invention has a glove palm, a glove back and an edging. The edging is a bent sheet and has an upper side edge and a lower side edge, wherein the lower and upper side edges are respectively adhered to the glove palm and the glove back via joining regions, and the lower and upper side edges bend toward the glove palm. Thus, the whole glove structure bends along a direction being from the glove back to the glove back to make the glove structure be a ergonomics structure which the fingers bend toward the glove palm when the human hand is under a working state or a general state without force.

Abstract: Disclosed are a phenyl amino sodium propionate derivative, a preparation method therefor and an application thereof. Specifically, disclosed are sodium 3-(4-(2-(9H-carbazole-9-yl)ethoxy)phenyl)-2-((2-(4-(4-(2-sodium forrnate-2-((2-(4-fluorobenzoyl)phenyl)amino)ethyl)phenoxy)benzoyl)phenyl)amino)propionate, a preparation method therefor and the use thereof for quality control of a bulk drug or formulation of Chiglitazar or a derivative thereof. Particularly, the compound can be used as a control substance or standard substance for the detection of impurities/related substances in Chiglitazar or a sodium salt drug thereof.

Abstract: The present disclosure discloses a method and a system for automatically resuming a call after network handover, and belongs to the field of network calls. In the method of the present disclosure, during a call between a first terminal and a second terminal, when the first terminal is handed over from a first network to a third network, the first terminal first stores call resources, then registers with a server through the third network, constructs a resume request, and sends the resume request to the second terminal via the server, and the second terminal resumes the call with the first terminal according to the resume request. The present disclosure can ensure communication stability after network handover of a communication device, thereby avoiding call interruption caused by the network handover during communication of the communication device.

Abstract: The invention relates to non-solvated crystals A, B and C of N-(2-aminophenyl)-6-(7-methoxyquinoline-4-oxy)-1-naphthamide and preparation methods thereof. The invention also relates to pharmaceutical compositions containing the crystals, and a use of the crystals in preparation of a medicament for the treatment of a disease associated with abnormal protein kinase activity or abnormal histone deacetylase activity.

Abstract: A height measuring apparatus. The height measuring apparatus includes a frame; a driving mechanism including a driving body that is connected with and movable along the frame and a moving part that is vertically movable with respect to the driving body. The driving body includes an altitude detector configured to detect an altitude of the moving part; a force transfer rod connected with the moving part to form a lever structure; a touching head connected with a first end of the force transfer rod; a dynamometer connected with a second end of the force transfer rod; a controller configured to stop the moving part from moving in response to the value of the force detected by the dynamometer reaching a predetermined force value; and a location detector configured to detect a location of a foreign object and send the detected location of the foreign object to the controller.

Abstract: Disclosed herein is a method for sharing auxiliary stream on a phone. By using the method as disclosed herein, the auxiliary information of the terminal is transferred to the opposite end by the way of signaling proxy through binding the audio and video phones with the terminal, to achieve sharing of auxiliary stream on the audio and video phones that do not support auxiliary stream function.

Abstract: The present invention relates to a urea compound and a preparation method and an application thereof. The structure of the present compound is represented by formula (I), the definition of each variable in the formula being as described in the description. The compound can block interaction between the PD-1/PD-L1 signalling pathways. The compound of the present invention can be used for treating or preventing diseases related to the signalling pathways, such as cancer, autoimmune disease, chronic infectious disease, and other diseases.

Abstract: Disclosed is a method for preparing 2-(2-(4-fluorobenzoyl)phenylamino)-3-(4-(2-(9H-carbazol-9-yl)ethoxy)phenyl)propanoic acid. In the method 9-carbazole ethanol mesylate and methyl 2-[2-(4-fluorobenzoyl)phenyl)amino]-3-(4-hydroxyphenyl)propionate are used as starting materials, and subjected to condensation, hydrolysis and acidification to obtain the target compound. The preparation method of the present invention is suitable for industrial production, and the target compound has a high purity.

Abstract: The invention discloses a type of fused imidazole compound, preparation method and application thereof. The structure of the compound is shown in general formula I. The definition of each group therein is as described in the specification. These compounds are capable of selectively inhibiting indoleamine 2,3-dioxygenase (IDO). The compounds can act as an IDO inhibitor for treating and/or preventing a disease having a pathological feature with IDO-mediated tryptophan metabolic pathways, for example, cancer, eye disease, autoimmune disease, psychological disorder, depression symptom, anxiety disorder and other diseases.

Abstract: The present invention discloses an enantiomeric compound (?)-2-[(2-(4-fluorobenzoyl)phenyl)amine]-3-[(4-(2-carbazole-ethoxy)phenyl)]propionic acid as represented by formula (I), or a pharmaceutical salt thereof, and a manufacturing method of the compound and application of same. The enantiomeric compound demonstrates relatively better activation of RXR/PPAR-, RXR/PPAR- and RXR/PPAR-heterodimer expression and sugar reduction in a db/db mouse model compared to a (+)-enantiomer.

Abstract: The invention relates to non-solvated crystals A, B and C of N-(2-aminophenyl)-6-(7-methoxyquinoline-4-oxy)-1-naphthamide and preparation methods thereof. The invention also relates to pharmaceutical compositions containing the crystals, and a use of the crystals in preparation of a medicament for the treatment of a disease associated with abnormal protein kinase activity or abnormal histone deacetylase activity.

Abstract: The invention discloses a type of fused imidazole compound, preparation method and application thereof. The structure of the compound is shown in general formula I. The definition of each group therein is as described in the specification. These compounds are capable of selectively inhibiting indoleamine 2,3-dioxygenase (IDO). The compounds can act as an IDO inhibitor for treating and/or preventing a disease having a pathological feature with IDO-mediated tryptophan metabolic pathways, for example, cancer, eve disease, autoimmune disease, psychological disorder, depression symptom, anxiety disorder and other diseases.

Abstract: In the present disclosure, a piece is disposed on a glove core of a glove structure, and an edge of the piece is to injected and filled with molding material to have an injection molding assembly thereon. The injection molding assembly at least fills a section gap between the glove core and the edge of the piece. By using the injection molding assembly, the section gap between the glove core and the edge of the piece is masked, and an adhesive effect for bonding the piece is also obtained. Thus, the present disclosure provides positive and reliable means for preventing the edge of the piece from being separated from the glove core, making the glove structure maintain its required function in long term, increasing the quality and the lifetime of the glove structure, and making the glove structure have a curved surface shape to present its three-dimensional shape.

Abstract: The present invention relates to a urea compound and a preparation method and an application thereof. The structure of the present compound is represented by formula (I), the definition of each variable in the formula being as described in the description. The compound can block interaction between the PD-1/PD-L1 signalling pathways. The compound of the present invention can be used for treating or preventing diseases related to the signalling pathways, such as cancer, autoimmune disease, chronic infectious disease, and other diseases.